Metraipolis › archive › dc_779de067e015

Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization — Europe PMC PMID:40834804

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40834804
DOI
10.1016/j.jacadv.2025.102075
License (as archived)
solo-consultazione
Archived
2026-11-10T12:56:55.548Z
SHA-256 of the archived text
7543328665032e8fabea5ce11c881a7f58cee1d13566ace9a656f5b96de1090a
Stable URL of this page
https://metraipolis.com/documento/dc_779de067e015

How to cite

Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization — Europe PMC PMID:40834804 — Europe PMC (en), https://europepmc.org/article/MED/40834804 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_779de067e015 (Metraipolis archive dc_779de067e015, sha256 7543328665032e8fabea5ce11c881a7f58cee1d13566ace9a656f5b96de1090a)
BibTeX
@misc{dc779de067e015,
  title = {Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization — Europe PMC PMID:40834804},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40834804},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_779de067e015; sha256 7543328665032e8fabea5ce11c881a7f58cee1d13566ace9a656f5b96de1090a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40834804. Agents can read the archived copy with the MCP tool read_document.